Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine rich adaptor protein 1-like (LURAP1L) is a protein coding gene that is predicted to play a role in the regulation of signal transduction, particularly in the positive regulation of canonical NF-kappaB signaling pathways. It is associated in some studies with retinitis pigmentosa subtypes, although its precise mechanistic role in disease is not well elucidated. LURAP1L is a member of a family of adaptor proteins characterized by leucine-rich repeats, primarily involved in intracellular signaling rather than serving as a classic drug target[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine rich adaptor protein 1-like (LURAP1L).